Sudden cardiac death
Unexpected natural death
From a cardiac cause
Within 1 hour of onset of symptoms
SCD- pathophysiology
 Substrate-
 Atherosclerosis, scar, hypertrophy, myocarditis/pathy
 Triggers
 Increased sympathetic/decreased parasympathetic drive,
electrolyte abnormality, drugs, stress
 Functional defect
 Electrolyte shift, electrical instability, platelet aggregation,
vasoconstriction, ischemia
 Rhythm disturbance
 VT, V-fib, asystole, EMD/PEA
SCD- etiology
 IHD
 Hypertrophy
 Cardiomyopathy- HOCM
 Valvular/congenital heart disease
 Primary electrical abnormality- LQTS,
idiopathic VT/VF, WPW syndrome
 Drugs/Toxins
Cardiac arrest
Cessation of normal blood
circulation, due to impaired heart
contractility
Cardiac arrest- S/S
Absent pulse- carotid
Altered sensorium/LOC
Impaired respiration
Cardiac arrest- causes
 Thrombosis- MI
 Thromboembolism-
PE
 Tension
pneumothorax
 Tamponade-
cardiac
 Trauma
 Tablets-
drugs/toxins
 Hypovolemia
 Hypoxia
 Hydrogen ions-
acidosis
 Hyper/hypokalemia
 Hypothermia
 Hypo/hyperglycemia
Cardiac arrest- prognosis
Out-of-hospital- <10% discharge
In-hospital- ~15% discharge
Worse prognosis
 Cardiogenic shock
 Age >60 years
 No MI
 Coma on admission
 >4 shocks required for resuscitation
 Bad to worse- VFVTasystolePEA/EMD
 Comorbidities- CHF, COPD, CAD, DM, HT
Chain of survival
 Early recognition
 No pulse, no breathing, LOC
 Early CPR/CCR
 Earlier the better, preferably within 6 minutes
 To circulate oxygenated blood, specially to brain & heart
 Chest compression + mouth-to-mouth breaths (30:2)
chest compressions only at ~100 per minute
 Early defibrillation
 Shock with 360 joules
 Early ACLS
 Using drugs & mechanical ventilation
Basic life support- CPR
BLS- CCR
ACLS
 Mechanical ventilation
 Access- IV, IO, ETT
 Vasopressor- Epinephrine
(Vasopressin)
 Tachycardia- Amiodarone
 Bradycardia- Atropine
 Correct underlying abnormality
Prevention of cardiac arrest
 Primary prevention- risk stratification
 History- elderly >65, s/s of CHF, syncope, DM,
smoking, A-fib, pacemaker
 LVEF- specially <30%
 ECG- IVCD, prolonged QT, LBBB, AV block, A-fib,
LVH
 EPS
 Rx for patients at increased risk- aspirin, β-blockers,
statins, ACEI, Amiodarone/Sotalol, AICD
Secondary prevention
 Correct underlying abnormality-
e.g. revascularization-
CABG/PTCA
 Amiodarone-asymp./Sotalol-symp. CHF
 Catheter ablation of arrythmia
 AICD (automated implantable
cardioverter defibrillator)
AICD- indications
 LVEF <30%, in NYHA class II/III, on
optimal drug therapy, with
expected survival of >1 year
 Prior MI with non-sustained VT or
inducible VT in EPS
 HOCM, LQTS, Brugada syndrome

Sudden cardiac death

  • 1.
    Sudden cardiac death Unexpectednatural death From a cardiac cause Within 1 hour of onset of symptoms
  • 2.
    SCD- pathophysiology  Substrate- Atherosclerosis, scar, hypertrophy, myocarditis/pathy  Triggers  Increased sympathetic/decreased parasympathetic drive, electrolyte abnormality, drugs, stress  Functional defect  Electrolyte shift, electrical instability, platelet aggregation, vasoconstriction, ischemia  Rhythm disturbance  VT, V-fib, asystole, EMD/PEA
  • 3.
    SCD- etiology  IHD Hypertrophy  Cardiomyopathy- HOCM  Valvular/congenital heart disease  Primary electrical abnormality- LQTS, idiopathic VT/VF, WPW syndrome  Drugs/Toxins
  • 4.
    Cardiac arrest Cessation ofnormal blood circulation, due to impaired heart contractility
  • 5.
    Cardiac arrest- S/S Absentpulse- carotid Altered sensorium/LOC Impaired respiration
  • 6.
    Cardiac arrest- causes Thrombosis- MI  Thromboembolism- PE  Tension pneumothorax  Tamponade- cardiac  Trauma  Tablets- drugs/toxins  Hypovolemia  Hypoxia  Hydrogen ions- acidosis  Hyper/hypokalemia  Hypothermia  Hypo/hyperglycemia
  • 7.
    Cardiac arrest- prognosis Out-of-hospital-<10% discharge In-hospital- ~15% discharge
  • 8.
    Worse prognosis  Cardiogenicshock  Age >60 years  No MI  Coma on admission  >4 shocks required for resuscitation  Bad to worse- VFVTasystolePEA/EMD  Comorbidities- CHF, COPD, CAD, DM, HT
  • 9.
    Chain of survival Early recognition  No pulse, no breathing, LOC  Early CPR/CCR  Earlier the better, preferably within 6 minutes  To circulate oxygenated blood, specially to brain & heart  Chest compression + mouth-to-mouth breaths (30:2) chest compressions only at ~100 per minute  Early defibrillation  Shock with 360 joules  Early ACLS  Using drugs & mechanical ventilation
  • 10.
  • 11.
  • 12.
    ACLS  Mechanical ventilation Access- IV, IO, ETT  Vasopressor- Epinephrine (Vasopressin)  Tachycardia- Amiodarone  Bradycardia- Atropine  Correct underlying abnormality
  • 13.
    Prevention of cardiacarrest  Primary prevention- risk stratification  History- elderly >65, s/s of CHF, syncope, DM, smoking, A-fib, pacemaker  LVEF- specially <30%  ECG- IVCD, prolonged QT, LBBB, AV block, A-fib, LVH  EPS  Rx for patients at increased risk- aspirin, β-blockers, statins, ACEI, Amiodarone/Sotalol, AICD
  • 14.
    Secondary prevention  Correctunderlying abnormality- e.g. revascularization- CABG/PTCA  Amiodarone-asymp./Sotalol-symp. CHF  Catheter ablation of arrythmia  AICD (automated implantable cardioverter defibrillator)
  • 15.
    AICD- indications  LVEF<30%, in NYHA class II/III, on optimal drug therapy, with expected survival of >1 year  Prior MI with non-sustained VT or inducible VT in EPS  HOCM, LQTS, Brugada syndrome